{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:51:40Z","timestamp":1772729500276,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bcp.2024.116092","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T16:13:28Z","timestamp":1708791208000},"page":"116092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The 8-hydroxyquinoline derivative, clioquinol, is an alpha-1 adrenoceptor antagonist"],"prefix":"10.1016","volume":"222","author":[{"given":"Ashenafi H.","family":"Betrie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Abdul-Ridha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herodion","family":"Hartono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-2427","authenticated-orcid":false,"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2024.116092_b0005","first-page":"157","article-title":"Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis","volume":"29","author":"Meade","year":"1975","journal-title":"Br. J. Prev. Soc. Med."},{"issue":"3","key":"10.1016\/j.bcp.2024.116092_b0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuro.2007.02.004","article-title":"Stoichiometry and conditional stability constants of CU(II) or ZN(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy","volume":"28","author":"Ferrada","year":"2007","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.bcp.2024.116092_b0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.bcp.2024.116092_b0020","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting a\u03b2 amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116092_b0025","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting a\u03b2 as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116092_b0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2011.07402.x","article-title":"The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity","volume":"119","author":"Crouch","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2024.116092_b0040","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.3c01771","article-title":"Discovery of novel 8-hydroxyquinoline derivatives with potent in vitro and in vivo antifungal activity","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116092_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110202","article-title":"Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model","volume":"38","author":"Brazel","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2024.116092_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114841","article-title":"Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease","volume":"244","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2024.116092_b0055","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/acs.jmedchem.2c01895","article-title":"Development of clioquinol PLATINUM(IV) conjugates as autophagy-targeted antimetastatic agents","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0060","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1038\/s41467-021-23198-6","article-title":"Zinc drives vasorelaxation by acting in sensory nerves, endothelium and smooth muscle","volume":"12","author":"Betrie","year":"2021","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.bcp.2024.116092_b0065","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/bph.14617","article-title":"Updates in the function and regulation of \u03b1(1) -adrenoceptors","volume":"176","author":"Akinaga","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116092_b0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/bph.13008","article-title":"Localization of \u03b1-adrenoceptors: JR vane medal lecture","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116092_b0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.bjp.0702598","article-title":"Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery","volume":"127","author":"Stam","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116092_b0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0165-6147(86)90383-4","article-title":"\u03b11-adrenoceptor subclassification in vascular smooth muscle","volume":"7","author":"Flavahan","year":"1986","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116092_b0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1537-1891(02)00336-1","article-title":"Evidence for the role of alpha1D- and alpha1A-adrenoceptors in contraction of the rat mesenteric artery","volume":"40","author":"Ar\u00e9valo-Le\u00f3n","year":"2003","journal-title":"Vascul. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(00)00220-X","article-title":"Alpha(1)-adrenoceptor subtypes mediating contractions of the rat mesenteric artery","volume":"395","author":"Hussain","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116092_b0095","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/acschembio.8b00191","article-title":"Determinants of ligand subtype-selectivity at \u03b1(1A)-adrenoceptor revealed using saturation transfer difference (STD) NMR","volume":"13","author":"Yong","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41467-021-27911-3","article-title":"Crystal structure of the alpha1B-adrenergic receptor reveals molecular determinants of selective ligand recognition","volume":"13","author":"Deluigi","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0105","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1038\/s41467-023-39310-x","article-title":"Structural basis of \u03b1(1A)-adrenergic receptor activation and recognition by an extracellular nanobody","volume":"14","author":"Toyoda","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2024.116092_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1056-8719(00)00121-0","article-title":"Techniques to study the pharmacodynamics of isolated large and small blood vessels","volume":"44","author":"Angus","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"2","key":"10.1016\/j.bcp.2024.116092_b0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-161093","article-title":"Evidence of a cardiovascular function for microtubule-associated protein tau","volume":"56","author":"Betrie","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(84)90105-5","article-title":"Reversible inhibition of neuronal uptake by benextramine, an irreversible presynaptic alpha-adrenoceptor antagonist","volume":"98","author":"Lew","year":"1984","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116092_b0125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/jm00209a007","article-title":"Molecular properties of the adrenergic.alpha. receptor. 2. Optimum covalent inhibition by two different prototypes of polyamine disulfides","volume":"21","author":"Melchiorre","year":"1978","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116092_b0130","unstructured":"S. Maestro, LLC. Schr\u00f6dinger release 2021-1, 2021."},{"key":"10.1016\/j.bcp.2024.116092_b0135","doi-asserted-by":"crossref","unstructured":"W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics, J. Mol. Graph. 14(1) (1996) 33-8, 27-8.","DOI":"10.1016\/0263-7855(96)00018-5"},{"key":"10.1016\/j.bcp.2024.116092_b0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"15","key":"10.1016\/j.bcp.2024.116092_b0145","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/jcc.24660","article-title":"CHARMM-GUI 10 years for biomolecular modeling and simulation","volume":"38","author":"Jo","year":"2017","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.bcp.2024.116092_b0155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2024.116092_b0160","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/bip.22868","article-title":"Improved model of hydrated calcium ion for molecular dynamics simulations using classical biomolecular force fields","volume":"105","author":"Yoo","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.bcp.2024.116092_b0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bpc.2016.05.006","article-title":"Molecular dynamics study of human carbonic anhydrase II in complex with Zn(2+) and acetazolamide on the basis of all-atom force field simulations","volume":"214\u2013215","author":"Wambo","year":"2016","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bcp.2024.116092_b0170","unstructured":"H. Motulsky, A. Christopoulos, ProQuest (Firm), Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting."},{"issue":"10","key":"10.1016\/j.bcp.2024.116092_b0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(00)89066-5","article-title":"Analysis of competitive agonist-antagonist interactions by nonlinear regression","volume":"16","author":"Lew","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2024.116092_b0185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1476-5381.1970.tb09903.x","article-title":"Uptake, metabolism and release of (3H)-adrenaline by human platelets","volume":"39","author":"Born","year":"1970","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0190","first-page":"136","article-title":"Effect of the chelating agents, EDTA, 2,2'-bipyridine, 8-hydroxyquinoline and pyrophosphoric acid, on norepinephrine uptake by rabbit aorta","volume":"163","author":"Nedergaard","year":"1968","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2024.116092_b0195","first-page":"705","article-title":"Developments of computer-based estimation of pA2 values and associated analysis","volume":"207","author":"Stone","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2024.116092_b0200","first-page":"678","article-title":"Alpha-1 adrenergic receptor binding and contraction of rat caudal artery","volume":"239","author":"Abel","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2024.116092_b0205","first-page":"517","article-title":"Nonlinear relationship between \u03b11-adrenergic receptor occupancy and norepinephrine-stimulated calcium flux in cultured vascular smooth muscle cells","volume":"27","author":"Colucci","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116092_b0210","series-title":"A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery","first-page":"119","article-title":"Chapter 6 \u2013 orthosteric drug antagonism","author":"Kenakin","year":"2014"},{"issue":"2","key":"10.1016\/j.bcp.2024.116092_b0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1152\/physiolgenomics.00065.2001","article-title":"A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse","volume":"9","author":"Daly","year":"2002","journal-title":"Physiol. Genomics"},{"issue":"15","key":"10.1016\/j.bcp.2024.116092_b0220","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1074\/jbc.M314014200","article-title":"Cell surface expression of \u03b11D-adrenergic receptors is controlled by heterodimerization with \u03b11B-adrenergic receptors","volume":"279","author":"Hague","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2024.116092_b0225","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41422-021-00557-y","article-title":"Structural mechanism of calcium-mediated hormone recognition and g\u03b2 interaction by the human melanocortin-1 receptor","volume":"31","author":"Ma","year":"2021","journal-title":"Cell Res."},{"issue":"47","key":"10.1016\/j.bcp.2024.116092_b0230","doi-asserted-by":"crossref","first-page":"15776","DOI":"10.1021\/ja806634e","article-title":"Organelle-specific zinc detection using zinpyr-labeled fusion proteins in live cells","volume":"130","author":"Tomat","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial a\u03b2","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bcp.2024.116092_b0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2011.01.009","article-title":"Clioquinol induces autophagy in cultured astrocytes and neurons by acting as a zinc ionophore","volume":"42","author":"Park","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2024.116092_b0245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00424-008-0532-3","article-title":"Vasomotion has chloride-dependency in rat mesenteric small arteries","volume":"457","author":"Boedtkjer","year":"2008","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.bcp.2024.116092_b0250","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1074\/jbc.M206424200","article-title":"Identification of an allosteric binding site for Zn2+ on the \u03b22 adrenergic receptor","volume":"278","author":"Swaminath","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2024.116092_b0255","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00424-012-1162-3","article-title":"Zinc modulation of basal and \u03b2-adrenergically stimulated L-type Ca2+ current in rat ventricular cardiomyocytes: consequences in cardiac diseases","volume":"464","author":"Alvarez-Collazo","year":"2012","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2024.116092_b0260","series-title":"Antifungal Antibiotics, StatPearls [internet]","author":"McKeny","year":"2023"},{"issue":"3 Pt 2","key":"10.1016\/j.bcp.2024.116092_b0265","first-page":"Ii34-6","article-title":"Side effects of vasodilator therapy","volume":"11","author":"Pettinger","year":"1988","journal-title":"Hypertension"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T19:57:28Z","timestamp":1711137448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":53,"alternative-id":["S0006295224000753"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116092","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 8-hydroxyquinoline derivative, clioquinol, is an alpha-1 adrenoceptor antagonist","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116092"}}